ApprovalTrail

Approval · Notice of Compliance 18137 · 2016

ALERTEC: Notice of Compliance 18137

Issued May 30, 2016

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
18137
Date
May 30, 2016
Company
Teva Canada LimitedToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Replacement of the drug substance manufacturing, release and stability testing site

Products in this notice

BrandDINStatus today
ALERTECNot yet assigned—

Medicinal ingredients